KR850004393A - 경구 투여용 지효성(遲效性) 아세틸살리실산 제제 - Google Patents

경구 투여용 지효성(遲效性) 아세틸살리실산 제제 Download PDF

Info

Publication number
KR850004393A
KR850004393A KR1019840008230A KR840008230A KR850004393A KR 850004393 A KR850004393 A KR 850004393A KR 1019840008230 A KR1019840008230 A KR 1019840008230A KR 840008230 A KR840008230 A KR 840008230A KR 850004393 A KR850004393 A KR 850004393A
Authority
KR
South Korea
Prior art keywords
acetylsalicylic acid
weight
acid formulation
oral administration
sustained release
Prior art date
Application number
KR1019840008230A
Other languages
English (en)
Inventor
스트레우프 베른하트트
Original Assignee
게르하르트 뷔네만 . 에리크 대브리츠
바이엘 악티엔 게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 게르하르트 뷔네만 . 에리크 대브리츠, 바이엘 악티엔 게젤샤프트 filed Critical 게르하르트 뷔네만 . 에리크 대브리츠
Publication of KR850004393A publication Critical patent/KR850004393A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

내용 없음

Description

경구투여용 지효성(遲효性) 아세틸살리실산 제제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (10)

  1. 아세틸살티실산 60%―90중량%, 전호화분 전분 8%―40중량% 및 첨가제 0―30중량%를 함유하는 지효성 아세틸살리실산 제제.
  2. 제1항에 있어서, 아세틸살리실산 70%―88중량%와 전호화분 전분 12―30중량%를 함유하는 아세틸살리실산 제제.
  3. 제1항 또는 제2항에 있어서, 질병 치료용으로 사용하는 아세틸살리실산 제제.
  4. 제1항 또는 제2항에 있어서, 통증, 염증 또는 혈소판 응집의 치료용으로 사용하는 아세틸살리실산 제제.
  5. 아세닐살리실산 60%―90중량%와 전호화분 진분에 8%―40중량% 및 첨가제 0―30중량%를 처리하여 정제 혼합물, 특히 과립상을 얻는 것을 특징으로 하는 지효성 아세틸살리실산제제의 제조방법.
  6. 제5항에 있어서, 건식 조립 방법을 행하는 것을 특징으로 하는 방법.
  7. 제6항에 있어서, 분말 상태로 전환시킴을 특징으로 하는 방법.
  8. 제6항에 있어서, 로울리으로 조립을 행함을 특징으로 하는 방법.
  9. 제1항 또는 제2항에 있어서 질병을 치료하기 위할 아세틸살리실산 제제의 사용.
  10. 제1항 또는 제2항에 있어서, 진통제 또는 소염제 또는 혈소판 응집영향제로서 아세틸살리실산 제제의 사용.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840008230A 1983-12-23 1984-12-21 경구 투여용 지효성(遲效性) 아세틸살리실산 제제 KR850004393A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3346571.1 1983-12-23
DE3346571A DE3346571A1 (de) 1983-12-23 1983-12-23 Oral retardierte acetylsalicylsaeureformulierungen

Publications (1)

Publication Number Publication Date
KR850004393A true KR850004393A (ko) 1985-07-15

Family

ID=6217790

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840008230A KR850004393A (ko) 1983-12-23 1984-12-21 경구 투여용 지효성(遲效性) 아세틸살리실산 제제

Country Status (12)

Country Link
US (1) US4601895A (ko)
EP (1) EP0146863A3 (ko)
JP (1) JPS60152411A (ko)
KR (1) KR850004393A (ko)
AU (1) AU3658984A (ko)
DE (1) DE3346571A1 (ko)
ES (1) ES8605676A1 (ko)
GR (1) GR82580B (ko)
HU (1) HU191738B (ko)
IL (1) IL73879A0 (ko)
PT (1) PT79701A (ko)
ZA (1) ZA8410045B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS615027A (ja) * 1984-06-18 1986-01-10 Sadahiro Nakano 徐放性固形製剤
DE3508097A1 (de) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
IT1191674B (it) * 1986-03-07 1988-03-23 Eurand Spa Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
GB8624213D0 (en) * 1986-10-09 1986-11-12 Sandoz Canada Inc Sustained release pharmaceutical compositions
US4855139A (en) * 1987-01-20 1989-08-08 Med. Fab (Lafayette), Inc. Fungicidally active cellulosic textile compositions, or articles of manufacture
US4904477A (en) * 1987-07-08 1990-02-27 American Home Products Corporation Spray dried ibuprofen compositions
US4857337A (en) * 1988-05-24 1989-08-15 American Home Products Corp. (Del) Enteric coated aspirin tablets
ZA942818B (en) * 1993-04-23 1995-01-30 Bio Technology General Corp Method of enhancing thrombolysis.
US5993860A (en) * 1993-06-17 1999-11-30 Venture Lending NSADI delivery employing a powdered hydrocolloid gum obtainable from higher plants
AU6403196A (en) * 1995-06-30 1997-02-05 Baylor University Polyester/carboxylic acid composite materials
JP4064476B2 (ja) * 1996-03-29 2008-03-19 エラワン ファーマスーティカル リサーチ アンドラボラトリー カンパニー リミテッド 二酸化珪素を有する球状凝集した澱粉
IN186245B (ko) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US6852337B2 (en) * 1998-04-09 2005-02-08 Roche Diagnostics Gmbh Carvedilol-galenics
WO2006061716A1 (en) * 2004-12-09 2006-06-15 Ragnar Ek Pharmaceutical formulation comprising low crystallinity cellulose

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE737909C (de) * 1940-11-19 1943-07-29 Apothekerschaft Deutsche Verfahren zur Beseitigung des Wasseranziehungsvermoegens und zur geschmacklichen Verbesserung arzneilich verwendbarer Stoffe
US3034911A (en) * 1959-03-25 1962-05-15 Nat Starch Chem Corp Tablet disintegrants
FR280067A (ko) * 1960-11-17
US3490742A (en) * 1966-01-14 1970-01-20 Staley Mfg Co A E Compressed tablets
US3622677A (en) * 1969-07-07 1971-11-23 Staley Mfg Co A E Compressed tablets containing compacted starch as binder-disintegrant ingredient
US3725556A (en) * 1970-11-12 1973-04-03 D Hanssen Method of manufacturing rapidly disintegrating pharmaceutical tablets
US4072535A (en) * 1970-12-28 1978-02-07 A. E. Staley Manufacturing Company Precompacted-starch binder-disintegrant-filler material for direct compression tablets and dry dosage capsules
US4328217A (en) * 1972-12-29 1982-05-04 Mead Johnson & Company Bran tablet composition and process
US3946110A (en) * 1974-05-30 1976-03-23 Peter, Strong Research And Development Company, Inc. Medicinal compositions and methods of preparing the same
US4086335A (en) * 1975-10-29 1978-04-25 Bruscato Frank N Pharmaceutical tablets containing chitin as a disintegrant
DE2708513C3 (de) * 1977-02-26 1981-01-08 C.H. Boehringer Sohn, 6507 Ingelheim Wasserunlösliche, physiologisch unbedenkliche Masse, Verfahren zu ihrer Herstellung und ihre Verwendung
US4198507A (en) * 1978-11-13 1980-04-15 Hoffmann-La Roche Inc. Theophylline magnesium salicylate
US4361545A (en) * 1979-05-21 1982-11-30 Rowell Laboratories, Inc. Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
US4308251A (en) * 1980-01-11 1981-12-29 Boots Pharmaceuticals, Inc. Controlled release formulations of orally-active medicaments
US4339428A (en) * 1980-08-18 1982-07-13 Bristol-Myers Company Capsule product containing high dosage of aspirin in powder or granulated form and alkaline tablet or pellet comprising magnesium carbonate, calcium carbonate and a magnesium dry component
US4439453A (en) * 1980-12-22 1984-03-27 Monsanto Company Directly compressible acetaminophen granulation
US4401665A (en) * 1981-04-14 1983-08-30 Bristol-Myers Company Sleep-aid composition containing an analgesic and diphenhydramine dihydrogencitrate, and method of use
US4375468A (en) * 1981-07-13 1983-03-01 Verex Laboratories, Inc. Constant order release aspirin composition and method of treating arthritis
US4369308A (en) * 1981-07-24 1983-01-18 National Starch And Chemical Corporation Low swelling starches as tablet disintegrants
US4390545A (en) * 1981-11-19 1983-06-28 American Cyanamid Company Combinations of agents which give enhanced anti-inflammatory activity
US4525345A (en) * 1981-12-24 1985-06-25 Verex Laboratories, Inc. Constant order release, solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
US4539198A (en) * 1983-07-07 1985-09-03 Rowell Laboratories, Inc. Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
US4551177A (en) * 1984-04-23 1985-11-05 National Starch And Chemical Corporation Compressible starches as binders for tablets or capsules

Also Published As

Publication number Publication date
JPS60152411A (ja) 1985-08-10
ZA8410045B (en) 1985-08-28
AU3658984A (en) 1985-06-27
ES538675A0 (es) 1986-04-01
PT79701A (en) 1985-01-01
EP0146863A2 (de) 1985-07-03
HUT36704A (en) 1985-10-28
EP0146863A3 (de) 1986-10-08
GR82580B (en) 1985-04-23
US4601895A (en) 1986-07-22
DE3346571A1 (de) 1985-07-04
HU191738B (en) 1987-04-28
ES8605676A1 (es) 1986-04-01
IL73879A0 (en) 1985-03-31

Similar Documents

Publication Publication Date Title
KR850004393A (ko) 경구 투여용 지효성(遲效性) 아세틸살리실산 제제
SE8004284L (sv) Terapeutisk preparat med forlengd, regelbunden utlosning av ett deri befintligt, terapeutiskt verksamt lekemedel
HUP0001849A2 (hu) S-Omeprazol új formája
ATE5125T1 (de) Pharmazeutische zusammensetzung, die sanguinaria und galangal enthaelt, zur behandlung von periodontitis und tumoren.
KR850000975A (ko) 발프로익산과 그 염의 혼합물을 토대로 한 조성물
IL58697A0 (en) Analgesic pharmaceutical compositions in the form of effervescent powders comprising metoclopramide
OA05577A (fr) Procédé de préparation de compositions pharmaceutiques renfermant des pyréthrinoïdes.
KR900017590A (ko) 좌창(Acne)치료방법 및 그 약제 조성물
ATE95070T1 (de) Pharmazeutische zusammensetzung mit gehalt an einer mischung von kollagen und einem antiseptischen und/oder entzuendungshemmenden wirkstoff und verfahren zu ihrer herstellung.
ES460098A1 (es) Metodo para producir derivados de acido penicilanico.
ES2130152T3 (es) Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
KR930000114A (ko) 지방산을 이용한 치료
JPS5572117A (en) Analgesic tablet and its manufacture
WO1987000432A3 (en) Use of melatonin or related compounds for the treatment of psoriasis
ES370058A1 (es) Procedimiento para la preparacion de composiciones farma- ceuticas efervescentes.
KR937000160A (ko) 사이클로덱스트린과 니메설리드의 포접 화합물
JPS5350141A (en) Stabilization of prostaglandin and prostaglandin analogues
MX9204748A (es) Derivados de acido mandelico substituidos y procedimientos para su preparacion.
US2906665A (en) L-amphetamine alginate
IT7950049A0 (it) Derivati acetilenici dell'androst-4-ene,procedimento per la loro produzione,loro impiego come medicamenti e composizioni farmaceutiche che licontengono
SE8704240L (sv) Analgetiska preparat
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법
KR890009868A (ko) 1-메틸-β-옥소-α-(페닐카바모일)-2- 피롤프로피오니트릴의 트로메트아민염
KR890001559A (ko) 트라피딜을 함유하는 제약 조성물, 그의 제조방법 및 관련된 치료 용도
JPS525769A (en) Preparation of 3-substituted pyrolidine derivatives

Legal Events

Date Code Title Description
SUBM Surrender of laid-open application requested